当前位置: 首页 > 期刊 > 《大家健康》 > 2009年第5期
编号:11794199
小儿流行性腮腺炎的临床治疗分析
http://www.100md.com 2009年5月1日 《大家健康》 2009年第5期
小儿流行性腮腺炎的临床治疗分析

     【摘要】目的:探讨小儿流行性腮腺炎的临床特点及治疗。方法:将我院140例流行性腮腺炎患儿随机分为治疗组及对照组,对照组患儿静脉滴注利巴韦林,治疗组患儿静脉滴注炎琥宁注射液。结果:经过治疗,两组患者症状均有明显缓解,治疗组退热时间、疼痛消失时间、肿胀消退时间均显著短于对照组,差异有统计学意义(P<0.05);治疗组的总有效率为95.7%,显著高于对照组的81.4%,差异有统计学意义(P<0.05)。两组均未发生严重不良反应。结论:炎琥宁治疗小儿流行性腮腺炎,可明显改善临床症状,且该药系中药注射剂,不良反应发生率低,经临床应用比较安全可靠,值得推广应用。

    【关键词】小儿;流行性腮腺炎;炎琥宁

    Children mumps clinical treatment Analysis

    【Abstract】 Objective Discuss children mumps clinical characteristics and treatment. Methods 140 cases patients mumps were randomly divided into treatment group and control group in our hospital,control group children were intravenous drip ribavirin,treatment group children were intravenous drip Dehydroandroandrographolide Succinate . Results After treatment,two groups patients symptoms were significantly alleviated,treatment group antipyretic time,pain and swelling disappearance time and subside time were significantly shorter than control group’s,there were significant differences(P<0.05); treatment group total effective rate was 95.7%,significantly higher than control group’s 81.4%,there were significant differences(P<0.05). two groups were no serious adverse reactions. Conclusion Potassium Sodium Dehydroandroandrographolide Succinate for Injection treatment children mumps,can significantly improve the clinical symptoms,and it’s Chinese medicine injections,adverse reactions incidence is low,is safe,reliable,and worthy of popularization. ......

您现在查看是摘要页,全文长 5578 字符